迈得医疗
(688310)
| 流通市值：24.67亿 | | | 总市值：24.67亿 |
| 流通股本：1.66亿 | | | 总股本：1.66亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 40,176,271.66 | 274,850,777.34 | 219,574,032.71 | 165,394,581.71 |
| 营业收入 | 40,176,271.66 | 274,850,777.34 | 219,574,032.71 | 165,394,581.71 |
| 二、营业总成本 | 60,784,570.29 | 318,484,947.58 | 236,252,326.53 | 166,500,744.77 |
| 营业成本 | 26,963,318.79 | 154,321,842.42 | 112,296,942.2 | 83,393,266.77 |
| 税金及附加 | 1,605,798.89 | 6,079,081.77 | 4,749,812.52 | 3,391,532.34 |
| 销售费用 | 4,792,140.24 | 25,043,561.91 | 21,646,541.66 | 14,277,868.18 |
| 管理费用 | 18,622,624.24 | 95,212,930.99 | 70,982,904.91 | 47,372,545.46 |
| 研发费用 | 9,155,975.84 | 40,411,899.21 | 28,854,806.83 | 20,296,139.69 |
| 财务费用 | -355,287.71 | -2,584,368.72 | -2,278,681.59 | -2,230,607.67 |
| 其中:利息费用 | 245,935.81 | 64,132.37 | 51,104.61 | 45,060.05 |
| 其中:利息收入 | 174,748.26 | 3,091,924.37 | 2,510,344.61 | 2,376,925.95 |
| 加:公允价值变动收益 | 608,227.12 | 3,064,357.51 | 2,231,445.22 | 1,286,962.15 |
| 加:投资收益 | -8,538.35 | -823,757.27 | -49,138.39 | -20,711.79 |
| 资产处置收益 | - | 440,196.02 | 481,041.13 | 144,230.1 |
| 资产减值损失(新) | -27,993.3 | -13,090,279.67 | -753,453.27 | -653,573.33 |
| 信用减值损失(新) | -713,060.15 | 3,726,813.69 | 213,832.51 | 1,312,264.02 |
| 其他收益 | 5,216,043.41 | 22,920,564.94 | 19,850,037.76 | 9,511,177.08 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -15,533,619.9 | -27,396,275.02 | 5,295,471.14 | 10,474,185.17 |
| 加:营业外收入 | 2,247,860 | 321,003.18 | 316,124.55 | 15,114.35 |
| 减:营业外支出 | 204,579.17 | 2,156,565.63 | 1,007,644.05 | 403,324.7 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -13,490,339.07 | -29,231,837.47 | 4,603,951.64 | 10,085,974.82 |
| 减:所得税费用 | -137,451.53 | 780,720.31 | 2,571,423.73 | 3,027,592.82 |
| 六、净利润 | -13,352,887.54 | -30,012,557.78 | 2,032,527.91 | 7,058,382 |
| 持续经营净利润 | -13,352,887.54 | -30,012,557.78 | 2,032,527.91 | 7,058,382 |
| 归属于母公司股东的净利润 | -10,797,370.24 | -19,981,182.92 | 7,629,882.29 | 9,879,902.6 |
| 少数股东损益 | -2,555,517.3 | -10,031,374.86 | -5,597,354.38 | -2,821,520.6 |
| (一)基本每股收益 | -0.07 | -0.12 | 0.05 | 0.06 |
| (二)稀释每股收益 | -0.07 | -0.12 | 0.05 | 0.06 |
| 八、其他综合收益 | -266,787.98 | 305,474.05 | 19,336.48 | 183,491.61 |
| 归属于母公司股东的其他综合收益 | -266,787.98 | 305,474.05 | 19,336.48 | 183,491.61 |
| 九、综合收益总额 | -13,619,675.52 | -29,707,083.73 | 2,051,864.39 | 7,241,873.61 |
| 归属于母公司股东的综合收益总额 | -11,064,158.22 | -19,675,708.87 | 7,649,218.77 | 10,063,394.21 |
| 归属于少数股东的综合收益总额 | -2,555,517.3 | -10,031,374.86 | -5,597,354.38 | -2,821,520.6 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |